Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
Authors
Robert Coleman,
David CameronDavid Dodwell,
Richard Bell,
Caroline Wilson,
Emma Rathbone,
Maccon Keane,
Miguel Gil‐Gil,
Roger Burkinshaw,
Robert Grieve,
Peter Barrett‐Lee,
Diana Ritchie,
Victoria Liversedge,
Samantha Hinsley +12 authors
,
Helen Marshall Tip Tip